SARS-CoV-2 Beta variant
SARS-CoV-2 Beta variant, also known as B.1.351, was first identified in South Africa in May 2020. This variant of SARS-CoV-2, the virus that causes COVID-19, has been associated with increased transmissibility and a potential reduction in vaccine efficacy compared to the original virus strain. The Beta variant has several mutations in the spike protein, which the virus uses to enter human cells, making it a subject of concern for public health officials and researchers worldwide.
Mutations and Characteristics[edit | edit source]
The Beta variant carries several notable mutations in its spike protein, including K417N, E484K, and N501Y. These mutations potentially enhance the virus's ability to bind to the ACE2 receptor on human cells, making it more infectious. The E484K mutation, in particular, has been linked to a possible decrease in neutralizing activity from antibodies generated by previous infection or vaccination, raising concerns about vaccine effectiveness against this variant.
Impact on Vaccine Efficacy[edit | edit source]
Studies have shown that vaccines are generally less effective against the Beta variant compared to the original virus strain. However, most vaccines continue to provide significant protection against severe disease, hospitalization, and death caused by the Beta variant. Vaccine manufacturers and researchers are continuously evaluating the efficacy of current vaccines against emerging variants and developing booster shots or modified vaccines as needed.
Global Spread and Surveillance[edit | edit source]
The Beta variant has been detected in multiple countries around the world, leading to increased surveillance and research to monitor its spread and impact. Governments and health organizations have implemented various measures, including travel restrictions and enhanced testing, to contain outbreaks of the Beta variant.
Public Health Response[edit | edit source]
In response to the Beta variant, public health strategies have emphasized the importance of vaccination, wearing masks, social distancing, and other preventive measures to reduce transmission. Ongoing research and surveillance are crucial to understanding the variant's characteristics, its impact on vaccine efficacy, and the development of strategies to mitigate its spread.
See Also[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
